Skip to content
value.today

Curevo, Inc.

🇺🇸 Seattle, Washington, USAPharmaceuticalsFounded 2021
Total raised
$110 M
3 rounds on record
Latest round
$42 M
Mar 2025
First round on record
Dec 2021
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Curevo, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2025$42 MNo. 3$10 to $50 million

Curevo, Inc.: Raise no. 3, Mar 2025

Investors in this round

11 investors had bought by the notice of Mar 18, 2025: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Curevo, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$42 M of $85 M offered; $42 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • George Simeon · Executive Officer, Director
  • Baeksik Bae · Director
  • Charles Petty · Director
  • Giovanni Mariggi · Director
  • Mario Barro · Director
  • Moncef Slaoui · Director
  • Tal Zaks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by George Simeon, Ceo. Source: SEC Form D, newest notice filed Mar 18, 2025. Read the notice at the SEC.

equitySEC
Nov 2022$22 MNo. 2$10 to $50 million

Curevo, Inc.: Raise no. 2, Nov 2022

Investors in this round

7 investors had bought by the notice of Nov 21, 2022: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Curevo, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$22 M of $26 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • George Simeon · Executive Officer, Director
  • Julie Brooks · Executive Officer
  • Baeksik Bae · Director
  • Charles Petty · Director
  • Jae Uk Jeong · Director
  • Mario Barro · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by George Simeon, Ceo. Source: SEC Form D, newest notice filed Nov 21, 2022. Read the notice at the SEC.

equitySEC
Dec 2021$46 MNo. 1$10 to $50 million

Curevo, Inc.: Raise no. 1, Dec 2021

Investors in this round

7 investors had bought by the notice of Jan 12, 2022: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 1 investor is named for Curevo, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$46 M of $71 M offered; $25 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • George Simeon · Executive Officer, Director
  • Julie Brooks · Executive Officer
  • Baeksik Bae · Director
  • Charles Petty · Director
  • Jae Uk Jeong · Director
  • Mario Barro · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by George Simeon, Ceo. Source: SEC Form D, newest notice filed Jan 12, 2022. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Curevo, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2025).

    SEC Form D · Mar 2025

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Mar 2025

That is all the official record says: Curevo, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

1 named in official filings. Open an investor to see everything it has backed.

Investors in Curevo, Inc.
InvestorKindAmountRoundRoleSource
Janus Henderson Global Life Sciences FundFund or asset manager$20 Mheldnot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 11 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Curevo, Inc.
NameRoleNamed in
George SimeonExecutive officerMar 2025
Julie BrooksExecutive officerNov 2022
Baeksik BaeDirectorMar 2025
Charles PettyDirectorMar 2025
George SimeonDirectorMar 2025
Giovanni MariggiDirectorMar 2025
Mario BarroDirectorMar 2025
Moncef SlaouiDirectorMar 2025
Tal ZaksDirectorMar 2025
Jae Uk JeongDirectorNov 2022